Abstract
AbstractDiabetes has long been considered a risk factor in implant therapy and impaired wound healing in soft and hard oral tissues. Magnesium has been proved to promote bone healing under normal conditions. Here, we elucidate the mechanism by which Mg2+ promotes angiogenesis and osseointegration in diabetic status. We generated a diabetic mice model and demonstrated the alveolar bone healing was compromised, with significantly decreased angiogenesis. We then developed Mg-coating implants with hydrothermal synthesis. These implants successfully improved the vascularization and osseointegration in diabetic status. Mechanically, Mg2+ promoted the degradation of Kelch-like ECH-associated protein 1 (Keap1) and the nucleation of nuclear factor erythroid 2-related factor 2 (Nrf2) by up-regulating the expression of sestrin 2 (SESN2) in endothelial cells, thus reducing the elevated levels of oxidative stress in mitochondria and relieving endothelial cell dysfunction under hyperglycemia. Altogether, our data suggested that Mg2+ promoted angiogenesis and osseointegration in diabetic mice by regulating endothelial mitochondrial metabolism.
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Buser, D., Sennerby, L. & De Bruyn, H. Modern implant dentistry based on osseointegration: 50 years of progress, current trends and open questions. Periodontology 73, 7–21 (2017).
2. De Angelis, F. et al. Implant survival and success rates in patients with risk factors: results from a long-term retrospective study with a 10 to 18 years follow-up. Rev. Med. Pharmacol. Sci. 21, 433–437 (2017).
3. de Oliveira, P. et al. Obesity/metabolic syndrome and diabetes mellitus on peri-implantitis. Trends Endocrinol. Metab. 31, 596–610 (2020).
4. Javed, F. & Romanos, G. E. Chronic hyperglycemia as a risk factor in implant therapy. Periodontology 81, 57–63 (2019).
5. Quan, Y. (ed.) Dental Implant Treatment in Medically Compromised Patients. (Springer Press, 2020).